Global Ursodeoxycholic Acid Drug Market Insights, Forecast to 2025
Summary
This report studies the global market size of Ursodeoxycholic Acid Drug in key regions like North America, Europe, Asia Pacific, South America and Middle East & Africa, focuses on the consumption of Ursodeoxycholic Acid Drug in these regions.
This research report categorizes the global Ursodeoxycholic Acid Drug market by top players/brands, region, type and end user. This report also studies the global Ursodeoxycholic Acid Drug market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The global Ursodeoxycholic Acid Drug market size was increased to 972.32 million US$ from 632.24 million US$ in 2014, and it will reach 2189.43 million US$ in 2025, growing at CAGR of 12.24% between 2019 and 2025. In terms of volume. The objectives of this study are to define, segment, and project the size of the Ursodeoxycholic Acid Drug market based on company, product type, end user and key regions.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
1 Dr. Falk Pharma
2 Daewoong Pharmaceutical
3 Teva
4 Humanwell
5 Mitsubishi Tanabe Pharma
6 Lannett
7 Mylan
8 Bruschettini
9 Impax
10 Shanghai Pharma
11 Grindeks
Ursodeoxycholic Acid Drug market size by type:
1 Capsule
2 Tablet
Ursodeoxycholic Acid Drug market size by Applications:
1 Gallstone
2 Hepatopathy
3 Biliary Disease
4 Other
Ursodeoxycholic Acid Drug market size by region
North America
United States
Canada
Mexico
Asia-Pacific
China
Japan
Korea
India
Southeast Asia
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Russia
Rest of Europe
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Egypt
South Africa
Rest of Middle East & Africa
- 1 Study Coverage
- 1.1 Ursodeoxycholic Acid Drug Product Introduction
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Ursodeoxycholic Acid Drug Market Size Growth Rate by Type
- 1.4.2 Capsule
- 1.4.3 Tablet
- 1.5 Market by Application
- 1.5.1 Global Ursodeoxycholic Acid Drug Market Size Growth Rate by Application
- 1.5.2 Gallstone
- 1.5.3 Hepatopathy
- 1.5.4 Biliary Disease
- 1.6 Study Objectives
- 1.7 Years Considered
- 2 Executive Summary
- 2.1 Global Ursodeoxycholic Acid Drug Market Size
- 2.1.1 Global Ursodeoxycholic Acid Drug Revenue 2014-2025
- 2.1.2 Global Ursodeoxycholic Acid Drug Sales 2014-2025
- 2.2 Ursodeoxycholic Acid Drug Growth Rate by Region
- 2.2.1 Global Ursodeoxycholic Acid Drug Sales by Region
- 2.2.2 Global Ursodeoxycholic Acid Drug Revenue by Region
- 3 Breakdown Data by Manufacturer
- 3.1 Ursodeoxycholic Acid Drug Sales by Manufacturer
- 3.1.1 Ursodeoxycholic Acid Drug Sales by Manufacturer
- 3.1.2 Ursodeoxycholic Acid Drug Sales Market Share by Manufacturer
- 3.2 Ursodeoxycholic Acid Drug Revenue by Manufacturer
- 3.2.1 Ursodeoxycholic Acid Drug Revenue by Manufacturer (2014-2019)
- 3.2.2 Ursodeoxycholic Acid Drug Revenue Share by Manufacturer (2014-2019)
- 3.2.3 Global Market Concentration Ratio (CR5)
- 3.3 Ursodeoxycholic Acid Drug Price by Manufacturer
- 3.4 Ursodeoxycholic Acid Drug Manufacturing Base Distribution, Product Types
- 3.4.1 Ursodeoxycholic Acid Drug Manufacturers Headquarters
- 3.4.2 Established Date of International Manufacturers
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
- 4 Breakdown Data by Type
- 4.1 Global Ursodeoxycholic Acid Drug Sales by Type
- 4.2 Global Ursodeoxycholic Acid Drug Revenue by Type
- 4.3 Ursodeoxycholic Acid Drug Price by Type
- 5 Breakdown Data by Application
- 5.1 Overview
- 5.2 Global Ursodeoxycholic Acid Drug Breakdown Data by Application
- 6 North America
- 6.1 North America Ursodeoxycholic Acid Drug by Country
- 6.1.1 North America Ursodeoxycholic Acid Drug Sales by Country
- 6.1.2 North America Ursodeoxycholic Acid Drug Revenue by Country
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Ursodeoxycholic Acid Drug by Type
- 6.3 North America Ursodeoxycholic Acid Drug by Application
- 7 Europe
- 7.1 Europe Ursodeoxycholic Acid Drug by Country
- 7.1.1 Europe Ursodeoxycholic Acid Drug Sales by Country
- 7.1.2 Europe Ursodeoxycholic Acid Drug Revenue by Country
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Ursodeoxycholic Acid Drug by Type
- 7.3 Europe Ursodeoxycholic Acid Drug by Application
- 8 Asia Pacific
- 8.1 Asia Pacific Ursodeoxycholic Acid Drug by Country
- 8.1.1 Asia Pacific Ursodeoxycholic Acid Drug Sales by Country
- 8.1.2 Asia Pacific Ursodeoxycholic Acid Drug Revenue by Country
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Southeast Asia
- 8.2 Asia Pacific Ursodeoxycholic Acid Drug by Type
- 8.3 Asia Pacific Ursodeoxycholic Acid Drug by Application
- 9 South America
- 9.1 South America Ursodeoxycholic Acid Drug by Country
- 9.1.1 South America Ursodeoxycholic Acid Drug Sales by Country
- 9.1.2 South America Ursodeoxycholic Acid Drug Revenue by Country
- 9.1.3 Brazil
- 9.1.4 Argentina
- 9.2 South America Ursodeoxycholic Acid Drug by Type
- 9.3 South America Ursodeoxycholic Acid Drug by Application
- 10 Middle East and Africa
- 10.1 Middle East and Africa Ursodeoxycholic Acid Drug by Country
- 10.1.1 Middle East and Africa Ursodeoxycholic Acid Drug Sales by Country
- 10.1.2 Middle East and Africa Ursodeoxycholic Acid Drug Revenue by Country
- 10.1.3 Egypt
- 10.1.4 South Africa
- 10.2 Middle East and Africa Ursodeoxycholic Acid Drug by Type
- 10.3 Middle East and Africa Ursodeoxycholic Acid Drug by Application
- 11 Company Profiles
- 11.1 Dr. Falk Pharma
- 11.1.1 Dr. Falk Pharma Company Details
- 11.1.2 Dr. Falk Pharma Business Overview
- 11.1.3 Dr. Falk Pharma Ursodeoxycholic Acid Drug Sales, Revenue and Gross Margin (2017-2019)
- 11.1.4 Dr. Falk Pharma Ursodeoxycholic Acid Drug Products Offered
- 11.1.5 Dr. Falk Pharma Recent Development
- 11.2 Daewoong Pharmaceutical
- 11.2.1 Daewoong Pharmaceutical Company Details
- 11.2.2 Daewoong Pharmaceutical Business Overview
- 11.2.3 Daewoong Pharmaceutical Ursodeoxycholic Acid Drug Sales, Revenue and Gross Margin (2017-2019)
- 11.2.4 Daewoong Pharmaceutical Ursodeoxycholic Acid Drug Products Offered
- 11.2.5 Daewoong Pharmaceutical Recent Development
- 11.3 Teva
- 11.3.1 Teva Company Details
- 11.3.2 Teva Business Overview
- 11.3.3 Teva Ursodeoxycholic Acid Drug Sales, Revenue and Gross Margin (2017-2019)
- 11.3.4 Teva Ursodeoxycholic Acid Drug Products Offered
- 11.3.5 Teva Recent Development
- 11.4 Humanwell Healthcare
- 11.4.1 Humanwell Healthcare Company Details
- 11.4.2 Humanwell Healthcare Business Overview
- 11.4.3 Humanwell Healthcare Ursodeoxycholic Acid Drug Sales, Revenue and Gross Margin (2017-2019)
- 11.4.4 Humanwell Healthcare Ursodeoxycholic Acid Drug Products Offered
- 11.4.5 Humanwell Healthcare Recent Development
- 11.5 Mitsubishi Tanabe Pharma
- 11.5.1 Mitsubishi Tanabe Pharma Company Details
- 11.5.2 Mitsubishi Tanabe Pharma Business Overview
- 11.5.3 Mitsubishi Tanabe Pharma Ursodeoxycholic Acid Drug Sales, Revenue and Gross Margin (2017-2019)
- 11.5.4 Mitsubishi Tanabe Pharma Ursodeoxycholic Acid Drug Products Offered
- 11.5.5 Mitsubishi Tanabe Pharma Recent Development
- 11.6 Lannett
- 11.6.1 Lannett Company Details
- 11.6.2 Lannett Business Overview
- 11.6.3 Lannett Ursodeoxycholic Acid Drug Sales, Revenue and Gross Margin (2017-2019)
- 11.6.4 Lannett Ursodeoxycholic Acid Drug Products Offered
- 11.6.5 Lannett Recent Development
- 11.7 Mylan
- 11.7.1 Mylan Company Details
- 11.7.2 Mylan Business Overview
- 11.7.3 Mylan Ursodeoxycholic Acid Drug Sales, Revenue and Gross Margin (2017-2019)
- 11.7.4 Mylan Ursodeoxycholic Acid Drug Products Offered
- 11.7.5 Mylan Recent Development
- 11.8 Bruschettini
- 11.8.1 Bruschettini Company Details
- 11.8.2 Bruschettini Business Overview
- 11.8.3 Bruschettini Ursodeoxycholic Acid Drug Sales, Revenue and Gross Margin (2017-2019)
- 11.8.4 Bruschettini Ursodeoxycholic Acid Drug Products Offered
- 11.9 Impax
- 11.9.1 Impax Company Details
- 11.9.2 Impax Business Overview
- 11.9.3 Impax Ursodeoxycholic Acid Drug Sales, Revenue and Gross Margin (2017-2019)
- 11.9.4 Impax Ursodeoxycholic Acid Drug Products Offered
- 11.9.5 Impax Recent Development
- 11.10 Shanghai Pharma
- 11.10.1 Shanghai Pharma Company Details
- 11.10.2 Shanghai Pharma Business Overview
- 11.10.3 Shanghai Pharma Ursodeoxycholic Acid Drug Sales, Revenue and Gross Margin (2017-2019)
- 11.10.4 Shanghai Pharma Ursodeoxycholic Acid Drug Products Offered
- 11.10.5 Shanghai Pharma Recent Development
- 11.11 Grindeks
- 11.11.1 Grindeks Company Details
- 11.11.2 Grindeks Business Overview
- 11.11.3 Grindeks Ursodeoxycholic Acid Drug Sales, Revenue and Gross Margin (2017-2019)
- 11.11.4 Grindeks Ursodeoxycholic Acid Drug Products Offered
- 11.11.5 Grindeks Recent Development
- 12 Future Forecast
- 12.1 Ursodeoxycholic Acid Drug Market Forecast by Region
- 12.1.1 Global Ursodeoxycholic Acid Drug Sales Forecast by Region 2020-2025
- 12.1.2 Global Ursodeoxycholic Acid Drug Revenue Forecast by Region 2020-2025
- 12.2 Ursodeoxycholic Acid Drug Market Forecast by Type
- 12.2.1 Global Ursodeoxycholic Acid Drug Sales Forecast by Type (2020-2025)
- 12.2.2 Global Ursodeoxycholic Acid Drug Revenue Forecast by Type (2020-2025)
- 12.3 Ursodeoxycholic Acid Drug Market Forecast by Application
- 12.4 North America Ursodeoxycholic Acid Drug Forecast
- 12.5 Europe Ursodeoxycholic Acid Drug Forecast
- 12.6 Asia Pacific Ursodeoxycholic Acid Drug Forecast
- 12.7 South America Ursodeoxycholic Acid Drug Forecast
- 12.8 Middle East and Africa Ursodeoxycholic Acid Drug Forecast
- 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter¡¯s Five Forces Analysis
- 14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Ursodeoxycholic Acid Drug Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
- 15 Research Findings and Conclusion
- 16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.1.1 Research Programs/Design
- 16.1.1.2 Market Size Estimation
- 16.1.1.3 Market Breakdown and Data Triangulation
- 16.1.2 Data Source
- 16.1.2.1 Secondary Sources
- 16.1.2.2 Primary Sources
- 16.2 Author Details
- 16.3 Disclaimer
- List of Tables and Figures
- Figure Ursodeoxycholic Acid Drug Product Picture
- Table Ursodeoxycholic Acid Drug Market Segments
- Table Key Manufacturers of Ursodeoxycholic Acid Drug Covered in 2018
- Table Global Ursodeoxycholic Acid Drug Market Size Growth Rate by Type (2019-2025) (K Units) & (Million US$)
- Figure Global Ursodeoxycholic Acid Drug Sales Market Share by Type in 2018 & 2025
- Figure Capsule Product Picture
- Figure Tablet Product Picture
- Table Global Ursodeoxycholic Acid Drug Market Size Growth Rate by Application (2019-2025) (K Units)
- Figure Global Ursodeoxycholic Acid Drug Sales Market Share by Application in 2018 & 2025
- Figure Gallstone
- Figure Hepatopathy
- Figure Biliary Disease
- Figure Ursodeoxycholic Acid Drug Report Years Considered
- Figure Global Ursodeoxycholic Acid Drug Market Size 2014-2025 (Million US$)
- Figure Global Ursodeoxycholic Acid Drug Sales 2014-2025 (K Units)
- Table Global Ursodeoxycholic Acid Drug Market Size by Region 2019-2025 (K Units) & (Million US$)
- Figure Global Ursodeoxycholic Acid Drug Market Size and Market Share by Regions 2019-2025
- Table Global Ursodeoxycholic Acid Drug Sales by Region 2014-2019 (K Units)
- Table Global Ursodeoxycholic Acid Drug Sales Market Share by Region 2014-2019
- Figure Global Ursodeoxycholic Acid Drug Sales Market Share by Region 2014-2019
- Figure Global Ursodeoxycholic Acid Drug Sales Market Share by Region in 2018
- Table Global Ursodeoxycholic Acid Drug Revenue by Region 2014-2019 (Million US$)
- Figure Global Ursodeoxycholic Acid Drug Revenue Market Share by Region 2014-2019
- Figure Global Ursodeoxycholic Acid Drug Revenue Market Share by Region in 2018
- Table Global Ursodeoxycholic Acid Drug Sales by Manufacturer (2017-2019) (K Units)
- Table Global Ursodeoxycholic Acid Drug Sales Share by Manufacturer (2017-2019)
- Figure Global Ursodeoxycholic Acid Drug Sales Share by Manufacturer in 2018
- Table Ursodeoxycholic Acid Drug Revenue by Manufacturer (2017-2019) (Million USD)
- Table Ursodeoxycholic Acid Drug Revenue Share by Manufacturer (2017-2019)
- Figure Ursodeoxycholic Acid Drug Revenue Share by Manufacturer in 2018
- Table Global Manufacturers Market Concentration Ratio (CR5)
- Table Key Manufacturers Ursodeoxycholic Acid Drug Price (2017-2019) (USD/Unit)
- Table Ursodeoxycholic Acid Drug Manufacturers Headquarters
- Table Established Date of International Manufacturers
- Table Manufacturers Mergers & Acquisitions, Expansion Plans
- Table Global Ursodeoxycholic Acid Drug Sales by Type (2014-2019) (K Units)
- Table Global Ursodeoxycholic Acid Drug Sales Share by Type (2014-2019)
- Figure Global Ursodeoxycholic Acid Drug Sales Market Share by Type (2014-2019)
- Figure Global Ursodeoxycholic Acid Drug Sales Market Share by Type in 2018
- Table Global Ursodeoxycholic Acid Drug Revenue by Type (2014-2019) (Million US$)
- Table Global Ursodeoxycholic Acid Drug Revenue Share by Type (2014-2019)
- Figure Global Ursodeoxycholic Acid Drug Revenue Market Share by Type (2014-2019)
- Figure Global Ursodeoxycholic Acid Drug Revenue Market Share by Type in 2018
- Table Ursodeoxycholic Acid Drug Price by Type (2014-2019) (USD/Unit)
- Table Global Ursodeoxycholic Acid Drug Sales by Application (2014-2019) (K Units)
- Table Global Ursodeoxycholic Acid Drug Sales Share by Application (2014-2019)
- Figure Global Ursodeoxycholic Acid Drug Market Share by Application (2014-2019)
- Figure Global Ursodeoxycholic Acid Drug Market Share by Application in 2018
- Figure North America Ursodeoxycholic Acid Drug Sales Growth Rate 2014-2019 (K Units)
- Figure North America Ursodeoxycholic Acid Drug Revenue Growth Rate 2014-2019 (Million US$)
- Table North America Ursodeoxycholic Acid Drug Sales by Country (2014-2019) (K Units)
- Table North America Ursodeoxycholic Acid Drug Sales Market Share by Country (2014-2019)
- Figure North America Ursodeoxycholic Acid Drug Sales Market Share by Country in 2018
- Table North America Ursodeoxycholic Acid Drug Revenue by Country (2014-2019) (Million US$)
- Table North America Ursodeoxycholic Acid Drug Revenue Market Share by Country (2014-2019)
- Figure North America Ursodeoxycholic Acid Drug Revenue Market Share by Country in 2018
- Figure United States Ursodeoxycholic Acid Drug Sales Growth Rate (2014-2019) (K Units)
- Figure United States Ursodeoxycholic Acid Drug Revenue Growth Rate (2014-2019) (Million US$)
- Figure Canada Ursodeoxycholic Acid Drug Sales Growth Rate (2014-2019) (K Units)
- Figure Canada Ursodeoxycholic Acid Drug Revenue Growth Rate (2014-2019) (Million US$)
- Figure Mexico Ursodeoxycholic Acid Drug Sales Growth Rate (2014-2019) (K Units)
- Figure Mexico Ursodeoxycholic Acid Drug Revenue Growth Rate (2014-2019) (Million US$)
- Table North America Ursodeoxycholic Acid Drug Sales by Type (2014-2019) (K Units)
- Table North America Ursodeoxycholic Acid Drug Sales Market Share by Type (2014-2019)
- Figure North America Ursodeoxycholic Acid Drug Market Share by Type in 2018